• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长非编码 RNA DUXAP9 通过与 SOX9 直接相互作用促进肝癌细胞干性。

Long non-coding RNA DUXAP9 promotes hepatocellular carcinoma cell stemness via directly interacting with sox9.

机构信息

Department of Medical Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China.

Department of Hepato-Biliary-Pancreatic and Vascular Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, P.R. China.

出版信息

Environ Toxicol. 2021 Sep;36(9):1793-1801. doi: 10.1002/tox.23300. Epub 2021 Jun 4.

DOI:10.1002/tox.23300
PMID:34086387
Abstract

Long non-coding RNA (LncRNA) DUXAP9 expression was recently found to be higher in hepatocellular carcinoma (HCC) tissues and cells, and correlated with a shorter overall survival of HCC patients. However, its roles in HCC progression have never been revealed. Here, the roles of DUXAP9 in HCC cell stemness are explored as cancer stem cells (CSCs) contribute to one of the root of cancer progression. We found that DUXAP9 positively regulated HCC cell stemness, as characterized by the change of sphere-formation ability, ALDH activity and stemness marker expression. Further luciferase reporter, mRNA stability and RNA-RNA in vitro interaction assays indicated that DUXAP9 directly bound to the 3' untranslated region (UTR) of sox9, enhanced the mRNA stability of sox9 and thus increased sox9 expression. Notably, the effects induced by DUXAP9 on HCC cell stemness depended on sox9 expression. Therefore, this work identifies a novel DUXAP9/sox9 axis essential for HCC cell stemness.

摘要

长非编码 RNA (LncRNA) DUXAP9 的表达最近在肝癌 (HCC) 组织和细胞中被发现更高,并且与 HCC 患者的总生存率更短相关。然而,其在 HCC 进展中的作用从未被揭示。在这里,我们探索了 DUXAP9 在 HCC 细胞干性中的作用,因为癌症干细胞 (CSCs) 是癌症进展的根源之一。我们发现 DUXAP9 正向调节 HCC 细胞干性,其特征在于球体形成能力、ALDH 活性和干性标志物表达的变化。进一步的荧光素酶报告基因、mRNA 稳定性和体外 RNA-RNA 相互作用试验表明,DUXAP9 直接结合到 SOX9 的 3'非翻译区 (UTR),增强了 SOX9 的 mRNA 稳定性,从而增加了 SOX9 的表达。值得注意的是,DUXAP9 对 HCC 细胞干性的影响取决于 SOX9 的表达。因此,这项工作确定了一个新的 DUXAP9/sox9 轴,对 HCC 细胞干性至关重要。

相似文献

1
Long non-coding RNA DUXAP9 promotes hepatocellular carcinoma cell stemness via directly interacting with sox9.长非编码 RNA DUXAP9 通过与 SOX9 直接相互作用促进肝癌细胞干性。
Environ Toxicol. 2021 Sep;36(9):1793-1801. doi: 10.1002/tox.23300. Epub 2021 Jun 4.
2
LncRNA increases osteosarcoma cell stemness and migration by enhancing SOX9 mRNA stability.长链非编码 RNA 通过增强 SOX9 mRNA 的稳定性增加骨肉瘤细胞的干性和迁移能力。
FEBS Open Bio. 2019 Mar 20;9(4):781-790. doi: 10.1002/2211-5463.12620. eCollection 2019 Apr.
3
LINC00052/miR-101-3p axis inhibits cell proliferation and metastasis by targeting SOX9 in hepatocellular carcinoma.LINC00052/miR-101-3p 轴通过靶向 SOX9 抑制肝癌细胞增殖和转移。
Gene. 2018 Dec 30;679:138-149. doi: 10.1016/j.gene.2018.08.038. Epub 2018 Aug 8.
4
LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3.LINC00680 通过海绵吸附 miR-568 来增强肝癌干细胞特性和化疗耐药性,从而上调 AKT3。
J Exp Clin Cancer Res. 2021 Jan 26;40(1):45. doi: 10.1186/s13046-021-01854-5.
5
A SOX9-AS1/miR-5590-3p/SOX9 positive feedback loop drives tumor growth and metastasis in hepatocellular carcinoma through the Wnt/β-catenin pathway.SOX9-AS1/miR-5590-3p/SOX9 正反馈环路通过 Wnt/β-catenin 通路驱动肝细胞癌的肿瘤生长和转移。
Mol Oncol. 2019 Oct;13(10):2194-2210. doi: 10.1002/1878-0261.12560. Epub 2019 Aug 31.
6
Incomplete radiofrequency ablation promotes the development of CD133 cancer stem cells in hepatocellular carcinoma cell line HepG2 via inducing SOX9 expression.不完全射频消融通过诱导 SOX9 表达促进肝癌细胞系 HepG2 中 CD133 癌症干细胞的发展。
Hepatobiliary Pancreat Dis Int. 2018 Oct;17(5):416-422. doi: 10.1016/j.hbpd.2018.09.012. Epub 2018 Sep 15.
7
CD73 sustained cancer-stem-cell traits by promoting SOX9 expression and stability in hepatocellular carcinoma.CD73 通过促进肝癌中 SOX9 的表达和稳定性来维持癌症干细胞特性。
J Hematol Oncol. 2020 Feb 5;13(1):11. doi: 10.1186/s13045-020-0845-z.
8
LncRNA THOR increases the stemness of gastric cancer cells via enhancing SOX9 mRNA stability.长链非编码RNA THOR通过增强SOX9信使核糖核酸的稳定性来提高胃癌细胞的干性。
Biomed Pharmacother. 2018 Dec;108:338-346. doi: 10.1016/j.biopha.2018.09.057. Epub 2018 Sep 15.
9
miR-613 inhibits liver cancer stem cell expansion by regulating SOX9 pathway.miR-613 通过调控 SOX9 通路抑制肝癌干细胞扩增。
Gene. 2019 Jul 30;707:78-85. doi: 10.1016/j.gene.2019.05.015. Epub 2019 May 7.
10
A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.一种新型长链非编码 RNA MCM3AP-AS1 通过靶向 miR-194-5p/FOXA1 轴促进肝癌的生长。
Mol Cancer. 2019 Feb 19;18(1):28. doi: 10.1186/s12943-019-0957-7.

引用本文的文献

1
Diverse functions of SOX9 in liver development and homeostasis and hepatobiliary diseases.SOX9在肝脏发育、稳态及肝胆疾病中的多种功能。
Genes Dis. 2023 Jun 24;11(4):100996. doi: 10.1016/j.gendis.2023.03.035. eCollection 2024 Jul.
2
The lncRNA lnc-TSI antagonizes sorafenib resistance in hepatocellular carcinoma via downregulating miR-4726-5p expression and upregulating KCNMA1 expression.长链非编码 RNA lnc-TSI 通过下调 miR-4726-5p 表达和上调 KCNMA1 表达拮抗肝癌索拉非尼耐药。
J Mol Histol. 2024 Feb;55(1):83-96. doi: 10.1007/s10735-023-10173-2. Epub 2024 Jan 2.
3
Yin Yang 1-Induced Long Noncoding RNA DUXAP9 Drives the Progression of Oral Squamous Cell Carcinoma by Blocking CDK1-Mediated EZH2 Degradation.
阴阳 1 诱导的长非编码 RNA DUXAP9 通过阻断 CDK1 介导的 EZH2 降解驱动口腔鳞状细胞癌的进展。
Adv Sci (Weinh). 2023 Sep;10(25):e2207549. doi: 10.1002/advs.202207549. Epub 2023 Jul 3.
4
Advance of SOX Transcription Factors in Hepatocellular Carcinoma: From Role, Tumor Immune Relevance to Targeted Therapy.SOX转录因子在肝细胞癌中的研究进展:从作用、肿瘤免疫相关性到靶向治疗
Cancers (Basel). 2022 Feb 24;14(5):1165. doi: 10.3390/cancers14051165.
5
Long non-coding RNA inhibits the stemenss of colorectal cancer cells through directly binding to RNA.长链非编码 RNA 通过直接结合 RNA 抑制结直肠癌干细胞。
Bioengineered. 2021 Dec;12(1):8698-8708. doi: 10.1080/21655979.2021.1977054.